Alpha Tau Medical Ltd. (DRTS) Misses Q4 EPS by 30c

Alpha Tau Medical Ltd. (NASDAQ: DRTS) reported Q4 EPS of ($0.42), $0.30 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Alpha Tau Medical Ltd. (DRTS) click here.

You May Also Be Interested In

• T-Mobile (TMUS) Tops Q2 EPS by 27c; offers outlook
• Quest Diagnostics (DGX) Tops Q2 EPS by 30c; updates guidance
• West Pharma (WST) Tops Q2 EPS by 29c ; Offers Guidance